Clinical trial
Duloxetine Versus Placebo in Chronic Low Back Pain
NCT00424593 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00424593 |
|---|---|
| Title | Duloxetine Versus Placebo in Chronic Low Back Pain |
| Official title | Effect of Duloxetine 60 mg to 120 mg Once Daily in Patients With Chronic Low Back Pain |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Back Pain Without Radiation |
| Intervention type | Drug |
| Interventions | Duloxetine, Placebo |
| Enrollment | 236 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Oct 1, 2008 |
| First posted | Jan 19, 2007 |
| Last update posted | Nov 20, 2009 |
| Countries | Brazil, France, Germany, Mexico, Netherlands |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: